Notice Title

Consent to the Distribution of New Medicines

Publication Date
9 Apr 2026

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2026-sl1873
Title
View PDF
File Type and Size
PDF (24 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Gliclazide Indoco
Active Ingredient: Gliclazide 80mg
Dosage Form: Tablet
New Zealand Sponsor: Miro Healthcare Limited
Manufacturer: Indoco Remedies Limited, Verna, India
   
Product: Midazolam Te Arai (2.5mg/0.5mL)
Active Ingredient: Midazolam 5mg/mL
Dosage Form: Oral Solution
New Zealand Sponsor: Te Arai BioFarma Limited
Manufacturer: Laboratorios Liconsa SA, Guadalajara, Spain
   
Product: Midazolam Te Arai (5mg/1mL)
Active Ingredient: Midazolam 5mg/mL
Dosage Form: Oral Solution
New Zealand Sponsor: Te Arai BioFarma Limited
Manufacturer: Laboratorios Liconsa SA, Guadalajara, Spain
   
Product: Midazolam Te Arai (7.5mg/1.5mL)
Active Ingredient: Midazolam 5mg/mL
Dosage Form: Oral Solution
New Zealand Sponsor: Te Arai BioFarma Limited
Manufacturer: Laboratorios Liconsa SA, Guadalajara, Spain
   
Product: Midazolam Te Arai (10mg/2mL)
Active Ingredient: Midazolam 5mg/mL
Dosage Form: Oral Solution
New Zealand Sponsor: Te Arai BioFarma Limited
Manufacturer: Laboratorios Liconsa SA, Guadalajara, Spain
   
Product: Nurofen Cold & Flu with Decongestant
Active Ingredients: Ibuprofen 200mg
Pseudoephedrine hydrochloride 30mg
Dosage Form: Tablet
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: Reckitt Benckiser Healthcare International Limited, Nottingham, United Kingdom
   
Product: Ozempic
Active Ingredient: Semaglutide 0.68mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturers: Novo Nordisk A/S, Brennum Park, Hillerod, Denmark
Novo Nordisk Pharmaceutical Industries LP, North Carolina, United States of America


Dated this 2nd day of April 2026.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).